calendar
9,871 catalysts · 9,524 approval · 5,000 device 510k · 4,728 grant · 2,604 8k filing · 2,000 device pma · 2,000 device recall
next 91 dayslessmore
MonWedFri
9,871 catalysts · 9,524 approval · 5,000 device 510k · 4,728 grant · 2,604 8k filing · 2,000 device pma · 2,000 device recall
Sponsor: MICRO LABS LTD INDIA. Form: TABLET. Route: ORAL
Sponsor: MICRO LABS LTD INDIA. Form: TABLET. Route: ORAL
Sponsor: MICRO LABS LTD INDIA. Form: TABLET. Route: ORAL
Sponsor: MICRO LABS LTD INDIA. Form: TABLET. Route: ORAL
Sponsor: HALEON US HOLDINGS. Form: SPRAY, METERED. Route: NASAL
Sponsor: ACTELION. Form: TABLET. Route: ORAL
Sponsor: LUPIN. Form: CAPSULE. Route: ORAL
Sponsor: INVAGEN PHARMS. Form: TABLET. Route: ORAL
Sponsor: LANNETT CO INC. Form: TABLET. Route: ORAL
Sponsor: ABBVIE. Form: CAPSULE, DELAYED REL PELLETS. Route: ORAL
Sponsor: CENTOCOR ORTHO BIOTECH INC. Form: INJECTABLE. Route: INJECTION
Sponsor: MOLNLYCKE HLTH. Form: SOLUTION. Route: TOPICAL
Sponsor: PH HEALTH. Form: FOR SOLUTION. Route: ORAL
Sponsor: ACTELION. Form: TABLET, FOR SUSPENSION. Route: ORAL
Sponsor: BRISTOL MYERS SQUIBB. Form: INJECTABLE. Route: INJECTION
Sponsor: NOVARTIS. Form: TABLET. Route: ORAL
Sponsor: CEPHALON. Form: TROCHE/LOZENGE. Route: TRANSMUCOSAL
Sponsor: CEPHALON. Form: TABLET. Route: BUCCAL, SUBLINGUAL
Sponsor: EDENBRIDGE PHARMS. Form: TABLET. Route: SUBLINGUAL
Sponsor: BAYER. Form: TABLET. Route: ORAL
Sponsor: XTTRIUM. Form: SOLUTION. Route: TOPICAL
Sponsor: IMMUNEX. Form: SYRINGE
Sponsor: NOVARTIS PHARMS CORP. Form: INJECTABLE. Route: INJECTION
Sponsor: XTTRIUM. Form: SOLUTION. Route: TOPICAL
Sponsor: INDIVIOR. Form: FILM. Route: BUCCAL, SUBLINGUAL
Sponsor: INDIVIOR. Form: FILM. Route: BUCCAL, SUBLINGUAL
Sponsor: UNICHEM. Form: TABLET. Route: ORAL
Sponsor: REGENERON PHARMACEUTICALS. Form: INJECTABLE. Route: INJECTION
Sponsor: MERCK SHARP DOHME. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: BRISTOL MYERS SQUIBB. Form: INJECTABLE. Route: INJECTION
Sponsor: SUN PHARM. Form: CAPSULE. Route: ORAL
Sponsor: SANDOZ. Form: SOLUTION/DROPS. Route: OPHTHALMIC
Sponsor: AMPHASTAR PHARMS INC. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: SANOFI-AVENTIS US. Form: SOLUTION. Route: SUBCUTANEOUS
Sponsor: ZYDUS PHARMS. Form: TABLET. Route: ORAL
Sponsor: MACLEODS PHARMS LTD. Form: TABLET. Route: ORAL
Sponsor: AMNEAL PHARMS NY. Form: CAPSULE. Route: ORAL
Sponsor: MANNKIND. Form: POWDER. Route: INHALATION
Sponsor: NOVARTIS. Form: TABLET. Route: ORAL
Sponsor: AUROLIFE PHARMA LLC. Form: TABLET. Route: ORAL
Sponsor: ABBVIE. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: ABBVIE. Form: TABLET, DELAYED RELEASE. Route: ORAL
Sponsor: EXELIXIS. Form: CAPSULE. Route: ORAL
Sponsor: IMMUNEX. Form: SYRINGE
Sponsor: PURDUE PHARMA LP. Form: FILM, EXTENDED RELEASE. Route: TRANSDERMAL
Sponsor: GLAXOSMITHKLINE LLC. Form: SUSPENSION. Route: ORAL
Sponsor: UNITED THERAP. Form: SOLUTION. Route: INHALATION
Sponsor: ACTELION. Form: TABLET. Route: ORAL
Sponsor: ACTELION. Form: TABLET, FOR SUSPENSION. Route: ORAL
Sponsor: PADAGIS US. Form: TABLET, EXTENDED RELEASE. Route: ORAL